- GSK Velu, Founder, Chairman and Managing Director of Neuberg Diagnostics, stated on September 2 that AI has become integral to diagnostic processes in both pathology and radiology.
- Velu explained that AI is now embedded in diagnostic imaging such as mammography, MRI, and CT scans, enabling doctors to process up to three times the volume of images.
- He added that this integration will deepen across pathology and radiology in the coming years, with AI and robotics being foundational to the future of healthcare.
- Velu outlined Neuberg Diagnostics' advanced capabilities, including one of the largest genomics processing centres in the region, with centres of excellence in Ahmedabad, Chennai, and a new one in Delhi.
- The company also has metabolomics centres in Ahmedabad, Chennai, and Bangalore, with plans to expand to Delhi soon.
- They are establishing a national centre of excellence for renal pathology in Delhi, featuring electron microscopy for renal biopsies.
- Dr Harsh Mahajan, Founder and Chairman of Mahajan Imaging & Labs, highlighted the joint venture's strengths, combining Neuberg's expertise in high-end pathology, genomics, metabolomics, molecular pathology, and proteomics with Mahajan's imaging, radiology, and nuclear medicine capabilities.
GSK Velu, MD of Neuberg Diagnostics, highlighted the transformative impact of artificial intelligence (AI) in healthcare, particularly in pathology and radiology. He stated, "AI is an integral part of diagnosis," allowing doctors to process up to three times more images in diagnostics, significantly enhancing efficiency.1
Velu elaborated on the future of healthcare, asserting that it will be built on two foundational pillars: AI and robotics. He noted that AI's integration into diagnostic imaging, such as mammography, MRI, and CT scans, is crucial for advancing medical practices. "Moving forward, AI will be embedded across both pathology and radiology," he said.
Neuberg Diagnostics operates one of the largest genomics processing centers in the region, with centers of excellence in Ahmedabad, Chennai, and a new facility launching in Delhi. Additionally, the company is expanding its metabolomics centres and establishing a national center of excellence for renal pathology in Delhi, featuring electron microscopy for renal biopsies.5
Dr. Harsh Mahajan, founder of Mahajan Imaging & Labs, emphasized the collaboration between their organizations, stating, "The reason for our joint venture is that Neuberg Diagnostics brings in a lot of strength in pathology, especially high-end pathology, genomics, metabolomics, molecular pathology, and proteomics." This partnership aims to leverage their combined expertise in imaging and diagnostics to enhance patient care.
“Velu noted AI enables doctors to process up to three times more images in mammography, MRI, and CT scans. Neuberg operates one of the largest genomics processing centers in the region, with new facilities in Delhi for genomics and renal pathology.”
The News Mill
